NO20065768L - Karbonsamid-opioidforbindelser - Google Patents

Karbonsamid-opioidforbindelser

Info

Publication number
NO20065768L
NO20065768L NO20065768A NO20065768A NO20065768L NO 20065768 L NO20065768 L NO 20065768L NO 20065768 A NO20065768 A NO 20065768A NO 20065768 A NO20065768 A NO 20065768A NO 20065768 L NO20065768 L NO 20065768L
Authority
NO
Norway
Prior art keywords
opioidforbindelser
karbonsamid
nervous system
central nervous
carboxamide
Prior art date
Application number
NO20065768A
Other languages
English (en)
Norwegian (no)
Inventor
John Robert Carson
Philip Pitis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35064532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20065768(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20065768L publication Critical patent/NO20065768L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20065768A 2004-05-14 2006-12-14 Karbonsamid-opioidforbindelser NO20065768L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57129804P 2004-05-14 2004-05-14
PCT/US2005/016581 WO2005113486A1 (fr) 2004-05-14 2005-05-11 Composes carboxamido opioides

Publications (1)

Publication Number Publication Date
NO20065768L true NO20065768L (no) 2007-02-07

Family

ID=35064532

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065768A NO20065768L (no) 2004-05-14 2006-12-14 Karbonsamid-opioidforbindelser

Country Status (22)

Country Link
US (2) US7244866B2 (fr)
EP (1) EP1748978B1 (fr)
JP (1) JP5420170B2 (fr)
KR (1) KR101204751B1 (fr)
CN (1) CN1984879B (fr)
AR (1) AR049276A1 (fr)
AU (1) AU2005245403B2 (fr)
BR (1) BRPI0511137A (fr)
CA (1) CA2566601C (fr)
CR (1) CR8811A (fr)
EA (1) EA013261B1 (fr)
EC (1) ECSP067008A (fr)
ES (1) ES2485867T3 (fr)
HK (1) HK1101246A1 (fr)
IL (1) IL179196A (fr)
MX (1) MXPA06013270A (fr)
NO (1) NO20065768L (fr)
NZ (1) NZ551288A (fr)
TW (1) TWI418345B (fr)
UA (1) UA90432C2 (fr)
WO (1) WO2005113486A1 (fr)
ZA (1) ZA200610446B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005113486A1 (fr) * 2004-05-14 2005-12-01 Janssen Pharmaceutica N.V. Composes carboxamido opioides
US20060254029A1 (en) * 2005-05-11 2006-11-16 Conrad Swenson Pocket loss prevention device
BRPI0811639A2 (pt) * 2007-05-31 2014-09-30 Sepracor Inc Cicloaquilaminas fenil substituídas como inibidores da recaptação de monoamina
WO2010107457A1 (fr) * 2009-03-19 2010-09-23 Alkermes, Inc. Dérivés de morphinane avec biodisponibilité orale élevée
HUE043963T2 (hu) * 2009-12-04 2019-09-30 Alkermes Pharma Ireland Ltd Morfinán származékok gyógyszer-túladagolás kezelésére
RS58312B1 (sr) 2010-08-23 2019-03-29 Alkermes Pharma Ireland Ltd Metode za lečenje povećanja telesne mase indukovane antipsihoticima
US9029543B2 (en) 2011-04-05 2015-05-12 Alkermes, Inc. Process for the synthesis of quaternary amine compounds
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
CN104159586A (zh) 2011-12-15 2014-11-19 阿尔科米斯制药爱尔兰有限公司 丁丙诺啡和μ阿片受体拮抗剂的组合物
EP3004114B1 (fr) 2013-05-24 2019-12-25 Alkermes Pharma Ireland Limited Analogues de morphane et morphinane, et procédés d'utilisation
WO2014190271A2 (fr) 2013-05-24 2014-11-27 Alkermes Pharma Ireland Limted Méthodes de traitement de symptômes de la dépression
CN104940709A (zh) * 2015-07-22 2015-09-30 张秋英 一种镇痛麻醉喷雾剂
CN105055756A (zh) * 2015-09-18 2015-11-18 张秋英 一种阴部挫伤用镇痛气雾剂
KR102603671B1 (ko) 2017-01-17 2023-11-17 메비아스 디스커버리 인코포레이티드 치환된 3-디알킬아미노메틸-피페리딘-4-일-벤즈아미드 및 이를 제조 및 사용하는 방법
EP4243768A1 (fr) 2020-11-12 2023-09-20 Alkermes Pharma Ireland Limited Comprimé multicouche à libération immédiate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2071897A1 (fr) 1989-12-28 1991-06-29 Richard A. Glennon Ligands du recepteur sigma et leur utilisation
US6071970A (en) 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
EP1944292B9 (fr) * 2000-10-31 2016-07-06 Rensselaer Polytechnic Institute 2,6-méthano-3-benzazocines 8-substituées et morphinanes 3-substituées en tant que ligands du récepteur d'opioides
DE10059413A1 (de) * 2000-11-30 2002-06-20 Gruenenthal Gmbh Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
WO2003048113A1 (fr) * 2001-11-30 2003-06-12 Sepracor Inc. Analogues de tramadole et leurs utilisations
DE10213051B4 (de) 2002-03-23 2013-03-07 Grünenthal GmbH Substituierte 4-Aminocyclohexanole
JP2006507277A (ja) * 2002-10-25 2006-03-02 ラボファーマ インコーポレイテッド ２４時間有効な持続放出トラマドール製剤
SI2653465T1 (sl) 2004-03-15 2016-10-28 Janssen Pharmaceutica N.V. Modulatorji opiodnih receptorjev
WO2005113486A1 (fr) * 2004-05-14 2005-12-01 Janssen Pharmaceutica N.V. Composes carboxamido opioides

Also Published As

Publication number Publication date
EP1748978A1 (fr) 2007-02-07
ES2485867T3 (es) 2014-08-14
IL179196A0 (en) 2007-03-08
KR101204751B1 (ko) 2012-11-27
IL179196A (en) 2012-10-31
ECSP067008A (es) 2006-12-29
MXPA06013270A (es) 2007-04-23
CR8811A (es) 2009-01-14
AR049276A1 (es) 2006-07-12
UA90432C2 (uk) 2010-04-26
BRPI0511137A (pt) 2007-11-27
CA2566601C (fr) 2013-04-09
JP5420170B2 (ja) 2014-02-19
US7745492B2 (en) 2010-06-29
US7244866B2 (en) 2007-07-17
EA013261B1 (ru) 2010-04-30
NZ551288A (en) 2010-10-29
JP2007537278A (ja) 2007-12-20
CA2566601A1 (fr) 2005-12-01
AU2005245403B2 (en) 2012-04-19
US20080280990A1 (en) 2008-11-13
HK1101246A1 (en) 2007-10-12
WO2005113486A1 (fr) 2005-12-01
AU2005245403A1 (en) 2005-12-01
TW200605871A (en) 2006-02-16
EP1748978B1 (fr) 2014-06-04
CN1984879A (zh) 2007-06-20
KR20070015613A (ko) 2007-02-05
US20050256203A1 (en) 2005-11-17
TWI418345B (zh) 2013-12-11
CN1984879B (zh) 2011-07-27
EA200602115A1 (ru) 2007-04-27
ZA200610446B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
NO20065768L (no) Karbonsamid-opioidforbindelser
MY144483A (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
SE0203713D0 (sv) Novel compounds
EA201071245A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс
MXPA06014721A (es) Derivados de alquinilo como moduladores de los receptores de glutamato metabotropico.
NO20061074L (no) Forbindelser og sammensetninger som inbibitorer av reseptortyrosinkinaseaktivitet
WO2003096983A3 (fr) Methode de traitement de troubles dyslipidemiques
TW200407305A (en) Novel compounds
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
MY145070A (en) Imidazolothiazole compounds for the treatment of disease
EA200600048A1 (ru) Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором
DE602006013191D1 (de) Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
WO2007047447A3 (fr) Analogues de compose diuretique ou de type diuretique
WO2005081619A3 (fr) Composes et procedes pour accroitre la neurogenese
NO20070914L (no) Fremgangsmater for behandling av nervesystemforstyrrelser og tilstander
WO2009105162A3 (fr) Procédés et composés pour le traitement ou la prévention de troubles liés à une substance
EA200602081A1 (ru) Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7
AU2003211040A8 (en) The eaat2 promoter and uses thereof
AU2002347984A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
EA200602084A1 (ru) Пиперазиновые производные алкилоксиндолов
DE602004019698D1 (de) Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin
ECSP066555A (es) Derivados de morfolina como inhibidores de la reabsorcion de norepinefrina
ATE412634T1 (de) Piperazinderivate von alkyloxindolen
NO20074562L (no) Fremgangsmater for behandling av Parkinsons sykdom
RS20060622A (en) Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application